As the world leader in ophthalmic clinical trials, Ora provides a complete range of development services, including drug, drug delivery, medical devices, and preclinical. Over the past 30 years, Ora has earned 34 regulation product approvals for our clients. Our validated, industry standard models and established methodologies are paving the way for future regulatory approvals, both in the US and around the world.
The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation
Mitotech S.A. announces the initiation of Phase II clinical trial in Dry Eye Patients Utilizing the Controlled Adverse Environment
SkQ1 proven effective in a topical ophthalmic formulation at preclinical stage of compound development
The challenges and opportunities health care companies are facing regarding innovation in clinical trials and product development
How different drug formulations and dosing regimens may help ensure that patients take their medicine.